Cargando…

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration

Metastatic non-small cell lung cancer (NSCLC) remains largely incurable and the prognosis is extremely poor once it spreads to the brain. In particular, in patients with brain metastases, the blood brain barrier (BBB) remains a significant obstacle for the biodistribution of antitumor drugs and immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hongxia, Harrison, Emily B., Li, Huizhong, Hirabayashi, Koichi, Chen, Jing, Li, Qi-Xiang, Gunn, Jared, Weiss, Jared, Savoldo, Barbara, Parker, Joel S., Pecot, Chad V., Dotti, Gianpietro, Du, Hongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021299/ https://www.ncbi.nlm.nih.gov/pubmed/35443752 http://dx.doi.org/10.1038/s41467-022-29647-0

Ejemplares similares

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
por: Reppel, Loïc, et al.
Publicado: (2022)

Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T Cells
por: Lee, Sung Hyun, et al.
Publicado: (2022)

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
por: Huckaby, Justin T, et al.
Publicado: (2021)

Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T-lymphocytes
por: Caruana, Ignazio, et al.
Publicado: (2015)

Fully human antibody V(H) domains to generate mono and bispecific CAR to target solid tumors
por: Wang, Guanmeng, et al.
Publicado: (2021)

Challenges of driving CD30-directed CAR-T cells to the clinic
por: Grover, Natalie S., et al.
Publicado: (2019)

IMMU-20. Effective CAR-T cell medulloblastoma therapy in an immunocompetent mouse model
por: Tsahouridis, Rania, et al.
Publicado: (2022)

Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas
por: Tschernia, Nicholas P, et al.
Publicado: (2023)

Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma
por: Voorhees, Timothy J., et al.
Publicado: (2022)

Activation and degranulation of CAR-T cells using engineered antigen-presenting cell surfaces
por: Dirar, Qassim, et al.
Publicado: (2020)

The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
por: Meier, Jeremy A., et al.
Publicado: (2022)

Scattered seeding of CAR T cells in solid tumors augments anticancer efficacy
por: Li, Hongjun, et al.
Publicado: (2021)

Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
por: Agarwalla, Pritha, et al.
Publicado: (2022)

Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma
por: Ogunnaike, Edikan A., et al.
Publicado: (2021)

Computationally Guided Design of Single-Chain Variable Fragment Improves Specificity of Chimeric Antigen Receptors
por: Krokhotin, Andrey, et al.
Publicado: (2019)

Charachterization and functional analysis of scFv-based CARs to redirect T cells to IL13Rα2-positive glioma
por: Krenciute, Giedre, et al.
Publicado: (2015)

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
por: Karlsson, Hannah, et al.
Publicado: (2015)

STING agonist promotes CAR T cell trafficking and persistence in breast cancer
por: Xu, Nuo, et al.
Publicado: (2020)

Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer
por: Patel, Shetal A., et al.
Publicado: (2021)

IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
por: Pang, Nengzhi, et al.
Publicado: (2021)

Combination of AAV-CCL19 and GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma
por: Meng, Min, et al.
Publicado: (2021)

Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors
por: Fang, Lin, et al.
Publicado: (2023)

Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression
por: Foster, Aaron E, et al.
Publicado: (2009)

Selective Elimination of a Chemoresistant Side-Population of B-CLL Cells by Cytotoxic T Lymphocytes in Subjects Receiving an Autologous hCD40L/IL-2 Tumor Vaccine
por: Foster, Aaron E, et al.
Publicado: (2010)

Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
por: Zhang, Qing, et al.
Publicado: (2017)

The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
por: Liu, Dongfang, et al.
Publicado: (2020)

Induced expression of CCL19 promotes the anti-tumor ability of CAR-T cells by increasing their infiltration ability
por: Hu, Jian-fei, et al.
Publicado: (2022)

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
por: Hoyos, Valentina, et al.
Publicado: (2010)

B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
por: Nehama, Dean, et al.
Publicado: (2019)

Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2
por: Liu, Tingting, et al.
Publicado: (2015)

CCL11 promotes migration and proliferation of mouse neural progenitor cells
por: Wang, Feifei, et al.
Publicado: (2017)

Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis
por: Wakabayashi, Kuninobu, et al.
Publicado: (2021)

CCL18 Knockdown Suppresses Cell Growth and Migration in Thyroid Cancer
por: Sun, Caixia, et al.
Publicado: (2022)

Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma
por: Ling, Zihang, et al.
Publicado: (2022)

An integrated model for predicting KRAS dependency
por: Tsai, Yihsuan S., et al.
Publicado: (2023)

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and tumor microenvironment, overcoming multiple obstacles of CAR T therapy for solid tumors
por: Wang, Yufeng, et al.
Publicado: (2023)

Lung cells support osteosarcoma cell migration and survival
por: Yu, Shibing, et al.
Publicado: (2017)

Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
por: Wang, Hongxia, et al.
Publicado: (2021)

Mice Lacking Expression of the Chemokines Ccl21-Ser and Ccl19 (plt Mice) Demonstrate Delayed but Enhanced T Cell Immune Responses
por: Mori, Shigeyuki, et al.
Publicado: (2001)

Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden
por: Biondi, Marta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8mlovatam931s5fk9v0e1iv72h